Gemcitabine-Induced Pulmonary Toxicity: A Case Report of Pulmonary Veno-Occlusive Disease
Introduction Gemcitabine is a chemotherapeutic agent frequently used by for the treatment of several malignancies both in the adjuvant and metastatic setting. Although myelosuppression is the most adverse event of this therapy, gemcitabine might induce severe pulmonary toxicities. We describe a case...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2015-01-01
|
| Series: | Clinical Medicine Insights: Oncology |
| Online Access: | https://doi.org/10.4137/CMO.S26537 |
Search Result 1
by Célia Turco, Marine Jary, Stefano Kim, Mélanie Moltenis, Bruno Degano, Philippe Manzoni, Thierry Nguyen, Bruno Genet, Marie-Blanche Valnet Rabier, Bruno Heyd, Christophe Borg
Published 2015-09-01
Get full textPublished 2015-09-01
Article